Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of MiNK Therapeutics (NASDAQ:INKT) through any online brokerage.
Other companies in MiNK Therapeutics’s space includes: Kezar Life Sciences Inc (NASDAQ:KZR), Estrella Immunopharma Inc (NASDAQ:ESLA), Atossa Therapeutics Inc (NASDAQ:ATOS), Aligos Therapeutics Inc (NASDAQ:ALGS) and Citius Oncology Inc (NASDAQ:CTOR).
MiNK Therapeutics has a consensus price target of $19.50.
The stock price for MiNK Therapeutics (NASDAQ: INKT) is $10.02 last updated April 2, 2026 at 7:38 PM EDT.
There are no upcoming dividends for MiNK Therapeutics.
MiNK Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for MiNK Therapeutics.
MiNK Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.